Brady Corporation Q1 FY2026 earnings call

Management Statement and Operational Highlights

• Financial Results: Organic sales grew 2.8% in Q1, with adjusted earnings per share growing 8%. GAAP pretax earnings increased 16.5%, net income increased 15.3%, and adjusted diluted EPS improved 8%. Operating cash flow increased 42.5% to $33.4 million, and free cash flow increased 38.8% to $22.4 million.
• Connected Products: Brady launched the BradyScan app, an industrial barcode scanning app with features like image to barcode, speech-to-barcode, security check, and geotagging.
• R&D Investment: R&D expense was $23.3 million (5.7% of sales) this quarter, up from $18.9 million (5% of sales) last year, a 23% increase.
• Regional Performance: Americas and Asia had strong organic sales growth; Europe and Australia saw improved segment profit due to cost reduction actions taken last year.

Segment Performance

• Americas and Asia Region: Sales were $268.9 million this quarter, up 9.6% from Q1 last year. Organic sales growth was 4.7%, with acquisitions adding 4.9%. The Wire Identification product line saw nearly 19% growth. Asia business had total organic sales growth of 11.9%, led by Japan, with outside China combined growth of nearly 20%. Reported segment profit increased 9% to $59.9 million, segment profit as a percentage of sales was 22.3%. Excluding certain items, segment profit increased 6.3%.
• Europe and Australia Region: Sales were $136.4 million this quarter. Organic sales declined 0.8%, but foreign currency translation added 4.3% for total growth of 3.5%. Reported segment profit increased 42.8% to $18.7 million, segment profit as a percentage of sales was 13.7%. Excluding certain items, segment profit increased 15%.

Guidance

• Adjusted Diluted EPS: Increased the bottom end of the full year fiscal 2026 adjusted diluted EPS guidance range from $4.85 to $5.15, with the new range $4.90 to $5.15. The GAAP EPS guidance range was updated to $4.57 to $4.82.
• Organic Sales: Expect low single-digit organic sales growth for the full year ending July 31, 2026.
• Other Guidance: Income tax rate is approximately 21%, depreciation and amortization expense is approximately $44 million, and capital expenditures are approximately $40 million. Risks include potential strengthening of the U.S. dollar, inflationary pressures unable to be offset in a timely manner, and an overall slowdown in economic activity.

Risks

• Potential strengthening of the U.S. dollar.
• Inflationary pressures that cannot be offset in a timely manner.
• Overall slowdown in economic activity.

Question and Answer

Q: Surprised by gross margin strength, reasons?

A: Price and supply chain moves to offset macroeconomic effects; tariff impact lower than projected.

Q: R&D run rate?

A: ~5.5% for the next few quarters, with some streamlining of R&D efforts but R&D remains a key investment.

Q: Cost-out actions impact?

A: ~80% of the benefit from cost-out actions was seen in Q1, with more to come but no additional restructuring charges anticipated.

Q: Cash conversion target?

A: Reasonable to expect improvement in cash conversion, with Q1 improvement due to timing factors.

Q: Inventory high reasons?

A: Due to acquisitions, supply chain changes, and production moves in Asia.

Q: Europe and Australia segment outlook?

A: No green shoots yet, but 2026 is expected to be better than 2025.

Q: BradyScan details?

A: Available on Android and Apple, consumer version free for 50 scans per month, industrial version for connected products like printers and readers.

Q: Gravotech and Mecco synergies?

A: Work in progress, focusing on heavy industrial manufacturing, with confidence in the long-term strategy despite the tough current environment.

Q: Gross margin outlook?

A: Engineered products help boost gross margin, but there's no specific target; focus is on growth over margin expansion.